Martin J. Driscoll, President and CEO at Spring Bank Pharmaceuticals, Inc. (SBPH), bought 2,000 shares at $12.28 ($25K) on 2017-08-03, disclosed to the SEC on 2017-08-03.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.28 | 1,000 | $12K | 49.7% |
| 2 | $12.43 | 1,000 | $12K | 50.3% |
| Total | $12.36 avg | 2,000 | $25K | 100% |
| Filing → |
| SBPH | BUY | 2019-05-29 | $60K | — | Filing → |
| SBPH | BUY | 2019-05-22 | $33K | — | Filing → |
| SBPH | BUY | 2019-04-30 | $73K | — | Filing → |